TY - JOUR
T1 - Thyroid dysfunction during treatment with systemic antineoplastic therapy for childhood cancer
AU - Lebbink, Chantal A.
AU - Lentjes, Eef G.W.M.
AU - Tissing, Wim J.E.
AU - van den Heuvel-Eibrink, Marry M.
AU - van Santen, Hanneke M.
AU - van Dalen, Elvira C.
N1 - Publisher Copyright:
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
PY - 2020/12/14
Y1 - 2020/12/14
N2 - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To gain insight into the occurrence of and risk factors for aberrant thyroid function parameters (i.e. TSH, free thyroxine (FT4)) as expression of hypothyroidism, hyperthyroidism, or NTI during cancer treatment in children treated with systemic antineoplastic therapy.
AB - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To gain insight into the occurrence of and risk factors for aberrant thyroid function parameters (i.e. TSH, free thyroxine (FT4)) as expression of hypothyroidism, hyperthyroidism, or NTI during cancer treatment in children treated with systemic antineoplastic therapy.
UR - http://www.scopus.com/inward/record.url?scp=85103068896&partnerID=8YFLogxK
U2 - 10.1002/14651858.CD013805
DO - 10.1002/14651858.CD013805
M3 - Article
AN - SCOPUS:85103068896
SN - 1469-493X
VL - 2020
JO - Cochrane Database of Systematic Reviews
JF - Cochrane Database of Systematic Reviews
IS - 12
M1 - CD013805
ER -